Detalles de la búsqueda
1.
Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis.
Hepatol Res;
53(4): 301-311, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36507871
2.
Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma.
Hepatol Res;
52(7): 630-640, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35417606
3.
Prognostic impact of worsening of esophageal varices after balloon-occluded retrograde transvenous obliteration.
J Gastroenterol Hepatol;
37(6): 1148-1155, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35430734
4.
Clinical course of hepatitis C virus-positive patients with decompensated liver cirrhosis in the era of direct-acting antiviral treatment.
Hepatol Res;
51(5): 517-527, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33507588
5.
Therapeutic efficacy of lenvatinib in hepatocellular carcinoma patients with portal hypertension.
Hepatol Res;
50(9): 1091-1100, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32559342
6.
Ultra-deep sequencing analysis of resistance-associated variants during retreatment with simeprevir-based triple therapy after failure of telaprevir-based triple therapy in patients with genotype 1 hepatitis C virus infection.
Hepatol Res;
47(8): 773-782, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27593967
7.
Impact of branched-chain amino acid supplementation on survival in patients with advanced hepatocellular carcinoma treated with sorafenib: A multicenter retrospective cohort study.
Hepatol Res;
46(10): 1002-10, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26690886
8.
Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study.
PLoS One;
19(1): e0294590, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38165900
9.
Neuroendocrine tumor of the minor duodenal papilla with lymph node metastasis: a case report and literature review.
Int Cancer Conf J;
12(4): 255-262, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37577347
10.
IgE Plasma Cell Leukemia Harboring t(11;14) and 1q Amplification.
Case Rep Hematol;
2023: 4747989, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37408875
11.
Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.
PLoS One;
18(2): e0281459, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36749777
12.
Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis C virus infection.
PLoS One;
15(6): e0234811, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32544182
13.
Baseline quasispecies selection and novel mutations contribute to emerging resistance-associated substitutions in hepatitis C virus after direct-acting antiviral treatment.
Sci Rep;
7: 41660, 2017 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28134353
14.
Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C.
PLoS One;
11(3): e0151828, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27002630
15.
Acute compartment syndrome as the initial manifestation of chronic-phase chronic myeloid leukemia: a case report and review of the literature.
J Med Case Rep;
10: 201, 2016 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27443161
16.
Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection.
J Gastroenterol;
50(7): 785-94, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25384794
17.
Using early viral kinetics to predict antiviral outcome in response-guided pegylated interferon plus ribavirin therapy among patients with hepatitis C virus genotype 1.
J Gastroenterol;
49(4): 737-47, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23689988
18.
Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients.
J Gastroenterol;
47(2): 169-78, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21947705
19.
Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin.
J Gastroenterol;
47(3): 334-42, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22109353
20.
Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection.
J Gastroenterol;
47(5): 577-85, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22231575
Resultados
1 -
20
de 20
1
Próxima >
>>